Providing Additional Information on the Safety and Effectiveness of an Ebola Vaccine

Clinical trial NCT03161366 · COMPLETED

Trial details

NCT number: NCT03161366
Sponsor: Epicentre
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2018-05-28
Primary completion: 2018-07-14
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.